Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Recurrent Follicular Lymphoma

The reemergence of follicular lymphoma after a period of remission.
National Institutes of Health

Related topics

Related topics

17 relations
Atypical lymphocyteB lymphoblastB-LymphocytesHematopoietic and Lymphoid Cell
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Combined Lenalidomide/Rituximab Active in Recurrent Follicular Lymphoma
Combined treatment with lenalidomide/rituximab resulted in better clinical response in patients with recurrent follicular… Expand
Is this relevant?
2012
2012
CALGB 50401: A randomized trial of lenalidomide alone versus lenalidomide plus rituximab in patients with recurrent follicular lymphoma.
8000 Background: Lenalidomide (L) and rituximab (R) are active as single agents in follicular (FL) and other B-cell lymphomas… Expand
Is this relevant?
2012
2012
Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma
Thirty-five consecutive patients with follicular lymphoma (FL) receiving SCT at our institution between January 2000 and December… Expand
  • table 1
  • figure 1
Is this relevant?
2010
2010
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia.
The combination of bortezomib and rituximab was evaluated in patients with mantle cell lymphoma (MCL), follicular lymphoma (FL… Expand
Is this relevant?
2010
2010
Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management.
BACKGROUND The impact of active surveillance, comprising annual computed tomography scanning and bone marrow biopsies, in the… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
BACKGROUND The current study was conducted to asses the safety profile and clinical activity of rituximab in combination with… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 4
Is this relevant?
2006
2006
EUS-guided FNA diagnosis of recurrent follicular lymphoma in the transverse colon.
 
Is this relevant?
2004
2004
Detection of BCL2-IGH rearrangement on paraffin-embedded tissue sections obtained from a small submucosal tumor of the rectum in a patient with recurrent follicular lymphoma.
A 59-year-old woman was admitted to our hospital because of recurrent follicular lymphoma (FL). Colonoscopic examination revealed… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.
PURPOSE To examine outcome of treatment for patients with recurrent follicular lymphoma. PATIENTS AND METHODS Two hundred… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
PURPOSE To assess myeloablative therapy with autologous bone marrow transplantation (ABMT) in younger patients with follicular… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE